Lv1
60 积分 2024-12-08 加入
EGFR activation limits the response of liver cancer to lenvatinib
1天前
已完结
MYC in liver cancer: mechanisms and targeted therapy opportunities
21天前
已完结
Abstract 1374: Lenvatinib, tri-specific targeted therapy to VEGFR/FGFR/RET, suppresses angiogenesis through the inhibition of both VEGFR and FGFR signaling pathways
30天前
已关闭
Inhibition of inflammasome activation via sphingolipid pathway in acute lung injury by Huanglian Jiedu decoction: An integrative pharmacology approach
1个月前
已完结
皖公网安备34019202002308
